Ming Zhao

Ming Zhao

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Phytomedicine
Verified
Journal Article
Closed access
YWYu Wang
Yu Wang
JLJian Li
Jian Li
LXLiying Xuan
Liying Xuan
YLYongfeng Liu
Yongfeng Liu
LSLiqun Shao
Liqun Shao
MZMing Zhao
Ming Zhao

17 April 2018 in Journal of Cellular Physiology
Verified
Journal Article
Open access
PDF file
YWYu Wang
Yu Wang
XCXiaoxue Cui
Xiaoxue Cui
YWYilin Wang
Yilin Wang
YFYao Fu
Yao Fu
XGXin Guo
Xin Guo
MZMing Zhao
Ming Zhao
Doxorubicin (Dox) is a highly effective antitumor antibiotic, however myocardial toxicity severely limits its use clinically. The pathogenesis of doxorubicin‐induced cardiomyopathy is unclear. In Dox cardiomyopathy mice, there is a decline in cardiac function, a change in myocardial pathology and a reduction in miR378* expression. Expression changes in calumenin, an endoplasmic reticulum stress (ERS) chaperone protein and pathway factor, as well as apoptosis, were observed in cardiomyocytes after doxorubicin‐induced injury. However, miR378* increased calumenin expression, eased ERS, and reduced cardiomyocyte apoptosis, while, silencing miR378* reduced calumenin expression, aggravated ERS, and increased cardiomyocyte apoptosis. The above results indicate that miR378* alleviates ERS and inhibits the activation of the ERS‐mediated apoptosis signaling pathway in cardiomyocytes via regulating calumenin expression, thereby reducing cardiomyocyte apoptosis after doxorubicin‐induced injury. Increasing miR378* expression may be a new way to improve cardiac function and quality of life in patients with Dox cardiomyopathy.

17 September 2016 in Heart and Vessels
Verified
Journal Article
Open access
PDF file
YWYu Wang
Yu Wang
YWYi-Li Wang
Yi-Li Wang
XHXia Huang
Xia Huang
YYYang Yang
Yang Yang
YZYa-Jun Zhao
Ya-Jun Zhao
MZMing Zhao
Ming Zhao
Atrial fibrillation (AF) is a complex disease with multiple inter-relating causes culminating in rapid atrial activation and atrial structural remodeling. The contribution of endoplasmic reticulum and mitochondria stress to AF has been highlighted. As the class III antiarrhythmic agent, ibutilide are widely used to AF. This study was designed to explore whether ibutilide could treat AF by inhibiting endoplasmic reticulum stress pathways and mitochondria stress. The neonatal rat cardiomyocytes were isolated and exposed to H2O2, ibutilide was add to the culture medium 12 h. Then the cell viability, oxidative stress levels and apoptotic rate were analyzed. In addition, endoplasmic reticulum stress related protein (GRP78, GRP94, CHOP), mitochondria-dependent protein (Bax, Bcl-2) and caspase-3/9/12 were identified by real-time PCR and western blot analysis. In our results, remarkable decreased cell viability and oxidative stress levels were detected in cardiomyocytes after treating with H2O2. The apoptotic rate and the expression of proteins involved in mitochondrial stress and endoplasmic reticulum stress pathways increased. While ibutilide significantly inhibited these changes. These data suggested that ibutilide serves a protective role against H2O2-induced apoptosis of neonatal rat cardiomyocytes, and the mechanism is related to suppression of mitochondrial stress and endoplasmic reticulum stress.

11 April 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YWYu Wang
Yu Wang
LXLiying Xuan
Liying Xuan
XCXiaoxue Cui
Xiaoxue Cui
YWYilin Wang
Yilin Wang
SCShaoqing Chen
Shaoqing Chen
MZMing Zhao
Ming Zhao
Ibutilide, a class III antiarrhythmic agent has been shown to be cardioprotective in treating atrial fibrillation, promoting cardioconversion and recently this agent has been shown to protect against ER stress induced apoptosis in cardiomyocytes. In this study we begin to identify the mechanism by which ibutilide exerts its cardioprotection in tunicamycin treated cardiomyocytes. We examined ER stress markers including calumenin; a calcium binding ER chaperone protein that has recently been linked to ER stress in cardiomyocytes, in our treated cells. To assess the effect of ibutilide we used the well characterized in vitro model of ER stress induced apoptosis in rat neonatal cardiomyocytes (RNC). RNC were treated with tunicamycin and the degree of ER stress was assessed by quantifying mRNA and protein levels of GRP78, GRP94 and calumenin, and examined the extent of apoptosis by assessing the protein levels of caspase-3/9/12, CHOP, ATF6, p-PERK, spliced XBP-1, the ratio of Bax/Bcl-2 and the percentage of deoxynucleotidyl-transferase- mediated dUTP nick end labeling (TUNEL) positive cells. We demonstrate ibutilide attenuated the up-regulation of ER stress markers GRP78 and GRP94 and rescued the decline in calumenin mRNA and protein levels in tunicamycin treated cardiomyocytes. The up-regulation of apoptotic markers caspase-3, CHOP, ATF6, p-PERK, spliced XBP-1, the ratio of Bax/Bcl-2 and the percentage of TUNEL positive cells were also attenuated after ibutilide treatment while the protein levels of Caspase-9 and Caspase-12 were unaffected. This study suggests another cardioprotective effect of the antiarrhythmic agent ibutilide whereby pretreatment leads to the attenuation of ER stress induced apoptosis by regulating calumenin expression. This study provides further evidence for the role of calumenin in the cardiomyocyte ER stress response.

13 November 2021 in Medical Molecular Morphology
Verified
Journal Article
Closed access
PDF file
LSLi Shaoqing
Li Shaoqing
ZTZhao Ting
Zhao Ting
HLhao liu
hao liu
ZHZhihui He
Zhihui He
WYWang Yu
Wang Yu
MZMing Zhao
Ming Zhao

1 January 2018
Verified
Journal Article
Closed access
YWYu Wang
Yu Wang
QZQingshan Zhang
Qingshan Zhang
CWChengxi Wei
Chengxi Wei
LZLin Zhao
Lin Zhao
XGXin Guo
Xin Guo
MZMing Zhao
Ming Zhao